Key points are not available for this paper at this time.
The World Health Organization (WHO) describes Obesity as a condition characterized by excessive deposition of body fat to the point where it adversely affects health. Body mass index (BMI) values within 25 and 29.9 kg/m2 and below 30 kg/m2 are two measures of the positive energy imbalance that leads to obesity. In 2000, World Health Organization identified Obesity as the most clearly evident yet most ignored public health problem worldwide. The World Health Organization ranks obesity as the second most dangerous disease in the world. The worldwide impact of Obesity is recorded to be 4 million obesity-related deaths and 40 million disability-adjusted life years among adults globally in 2015. Family history, frequent overeating patterns, and lack of physical activity are all significant risk factors. When treating Sthula (obese patients), Ruksha Udvartana is mentioned, which involves using a dry powder of herbs without oil is used. Therefore, for the current study, it was decided to choose the Rodhradigana Udvartana followed by Bhaspaswedana and Gomaya Mashi Udvartana followed by Bhaspaswedana as a comparative study. The purpose of the current study is to document and examine this process for statistical interpretation. Aim: Evaluation of Comparative efficacy of Rodhradi Gana Udvartana with Bhaspaswedana and Gomaya Mashi Udvartana with Bhaspawedana in the management of Sthoulya (obesity). Material and Methods: Data related to the disease as well as the drug was collected from Samhitas, other classical Ayurvedic literature, and various modern science books. Subjects visited to outdoor and indoor Panchakarma department and from the specialty camps were registered for the present study. Result: Significant improvement was observed in both groups and during comparison, more results were found in the Gomaya Mashi group (Group B). Conclusion: Udvartana with Gomaya Mashi followed by Bhaspasweda is more effective than Udvartana with Rodhradi Gana followed by Bhaspasweda in the management of Sthoulya (Overweight) and is an economical alternative without adverse effects.
Verma et al. (Wed,) studied this question.